Exact Sciences
EXAS
#1148
Rank
$20.02 B
Marketcap
$104.91
Share price
0.00%
Change (1 day)
94.96%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2023 (TTM): -$1.59

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is -$5.32. In 2022 the company made an earnings per share (EPS) of -$3.54 a decrease over its 2021 EPS that were of -$3.46.

EPS history for Exact Sciences from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.59-55.21%
2022-$3.542.31%
2021-$3.46-37.09%
2020-$5.50674.65%
2019-$0.71-50.69%
2018-$1.4444%
2017-$1.00-39.39%
2016-$1.65-2.94%
2015-$1.7037.1%
2014-$1.2479.71%
2013-$0.69-21.59%
2012-$0.8862.96%
2011-$0.5492.86%
2010-$0.28-3.45%
2009-$0.29-19.44%
2008-$0.36-18.18%
2007-$0.44-10.2%
2006-$0.49-10.91%
2005-$0.55-24.66%
2004-$0.73-51.33%
2003-$1.50-7.41%
2002-$1.6211.72%
2001-$1.45

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
$1.90-135.77%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
$1.44-127.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
$0.34-106.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-$1.19-77.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-$50.90 856.77%๐Ÿ‡บ๐Ÿ‡ธ USA